The consensus price target hints at a 120.5% upside potential for Maze Therapeutics, Inc. (MAZE). Wh

This clinical-stage biotech targeting kidney and metabolic diseases reported a notable insider sale,

Maze Therapeutics, Inc. (MAZE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 20

SOUTH SAN FRANCISCO, Calif. , May 27, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE

Maze Therapeutics is a U.S. biotech advancing clinical-stage precision medicines for renal and metab

Maze Therapeutics, Inc. (MAZE) came out with a quarterly loss of $0.45 per share versus the Zacks Co

Maze Therapeutics (NASDAQ:MAZE) reported quarterly losses of $(0.45) per share which beat the analys

Positive topline data from Phase 2 HORIZON trial of MZE829 in patients with broad AMKD provide proof

This clinical-stage biotech focused on precision medicines for renal and metabolic diseases just rep

SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZ

Truist Securities analyst Danielle Brill maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy and

Chief Medical Officer Harold Bernstein sold 15,000 company shares for a transaction value of ~$442,0

JP Morgan analyst Anupam Rama maintains Maze Therapeutics (NASDAQ:MAZE) with a Overweight and rai

I am initiating coverage on Maze Therapeutics (MAZE) with a "Buy" rating following positive phase 2

The heavy selling pressure might have exhausted for Maze Therapeutics, Inc. (MAZE) as it is technica

SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims

The Dow Jones index gained over 300 points, with the S&P 500 and NASDAQ also rising. Cintas Corp

An executive at Maze Therapeutics reported selling 15,000 shares on March 20, 2026, yielding a trans

US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics sur

BTIG analyst Julian Harrison reiterates Maze Therapeutics (NASDAQ:MAZE) with a Buy and maintains

• Maze Therapeutics stock is among today's weakest performers. What's behind MAZE decline?

Maze Therapeutics stock drops despite Phase 2 data showing uACR reductions in APOL1 kidney disease;

HC Wainwright & Co. analyst Ananda Ghosh maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy

 – At week 12, treatment with MZE829 resulted in a 35.6% mean uACR reduction in broad AMKD patients,

Maze Therapeutics (NASDAQ:MAZE) reported quarterly losses of $(0.65) per share which beat the analys

Positive topline data from Phase 2 HORIZON trial of MZE829 demonstrating first clinical proof-of-con

– At week 12, treatment with MZE829 resulted in a 35.6% mean uACR reduction in broad AMKD patients,

One of Maze Therapeutics' executives exercised and sold 30,000 shares on March 10, 2026, generating

Wall Street analysts have changed their outlook on top names, with new coverage and price targets. S

Truist Securities analyst Danielle Brill initiates coverage on Maze Therapeutics (NASDAQ:MAZE) wi

Wedbush analyst Laura Chico maintains Maze Therapeutics (NASDAQ:MAZE) with a Outperform and raise

Analysts change outlook on top names, including initiations, upgrades, and downgrades. MSTR has a $1

Mizuho analyst Salim Syed initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Outperform

BTIG analyst Julian Harrison reiterates Maze Therapeutics (NASDAQ:MAZE) with a Buy and maintains

Guggenheim analyst Debjit Chattopadhyay maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy and

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE

BTIG analyst Julian Harrison maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy and raises the

Wells Fargo analyst Sadia Rahman initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Ove

HC Wainwright & Co. analyst Ananda Ghosh maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy

Wedbush analyst Laura Chico maintains Maze Therapeutics (NASDAQ:MAZE) with a Outperform and raise

Maze Therapeutics, Inc. (NASDAQ:MAZE), a clinical-stage biopharmaceutical company developing small m